NDC codes

FDA NDC Directory
Product NDC (as listed)0904-6874Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00904-6874Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0904-6874-040090468740430 BLISTER PACK in 1 CARTON (0904-6874-04) / 1 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Dec 17, 2012
0904-6874-060090468740650 BLISTER PACK in 1 CARTON (0904-6874-06) / 1 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Dec 17, 2012

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Abacavir
Generic name (nonproprietary)
abacavir
Active ingredients
Abacavir sulfate — 300 mg/1
Dosage form
Tablet, Film coated
Route
Oral
Labeler
Major PharmaceuticalsNDC labeler code 0904
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 077844
Marketing start
Listing expires
Other FDA classes
Cytochrome P450 1A1 Inhibitors (Mechanism)Nucleoside Reverse Transcriptase Inhibitors (Mechanism)
Identifiers
Product ID 0904-6874_8a0bf056-72b0-4a2e-8eb8-988fbf101b5dSPL ID 8a0bf056-72b0-4a2e-8eb8-988fbf101b5dSPL set ID 4b286ec6-68a7-4ec0-af07-5a27ec9cb35dRxCUI 242679UNII J220T4J9Q2
Pharmacologic class
Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400904687404 followed by a unit qualifier and the quantity

Package 00904-6874-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Abacavir tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus (HIV-1) infection. Abacavir tablets, a nucleoside analogue human immunodeficiency virus (HIV-1) reverse transcriptase inhibitor, are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0904-6874

What is NDC 0904-6874?
0904-6874 is the product NDC for Abacavir, Abacavir sulfate 300 mg/1 tablet, film coated, listed with the FDA by Major Pharmaceuticals. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Abacavir.
What is the active ingredient?
Abacavir sulfate.
Who is the labeler?
Major Pharmaceuticals, NDC labeler code 0904. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Abacavir?
10 other product NDCs are listed under this name. See all Abacavir NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Abacavir NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
AbacavirAbacavir sulfate 300 mg/1TabletOralXLCare Pharmaceuticals Inc.72865-16772865-0167-60
AbacavirAbacavir sulfate 300 mg/1TabletOralCamber Pharmaceuticals, Inc.31722-55731722-0557-60
AbacavirAbacavir sulfate 300 mg/1TabletOralCoupler LLC67046-160267046-1602-03
AbacavirAbacavir sulfate 300 mg/1TabletOralAvPAK50268-04950268-0049-12
Abacavirabacavir sulfateAbacavir sulfate 20 mg/mLSolutionOralRising Pharma Holdings, Inc.64980-40564980-0405-24
Abacavirabacavir sulfateAbacavir sulfate 20 mg/mLSolutionOralAurobindo Pharma Limited65862-08965862-0089-24
AbacavirAbacavir sulfate 300 mg/1Tablet, Film coatedOralCipla USA Inc.69097-51469097-0514-03
AbacavirAbacavir sulfate 20 mg/mLSolutionOralCamber Pharmaceuticals, Inc.31722-56231722-0562-24
AbacavirAbacavir sulfate 300 mg/1Tablet, Film coatedOralAmerican Health Packaging68084-02168084-0021-21
AbacavirAbacavir sulfate 300 mg/1Tablet, Film coatedOralAurobindo Pharma Limited65862-07365862-0073-60

Other NDCs under ANDA 077844

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077844
ProductStrengthForm · routeLabelerProduct NDC
AbacavirAbacavir sulfate 300 mg/1Tablet, Film coatedOralAurobindo Pharma Limited65862-073
AbacavirAbacavir sulfate 300 mg/1Tablet, Film coatedOralAmerican Health Packaging68084-021

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in